... loss and neurodevelopmental disability. First-trimester and periconceptional period are the most vulnerable times for fetal injury. Universal serological cytomegalovirus (CMV) screening in pregnant women is not currently recommended. After a recent randomized controlled clinical trial that demonstrated...

...). Conclusion: The first trimester prediction model for GDM with maternal characteristics and obstetric history achieves moderate predictability. The inclusion of MAP in the model combining maternal characteristics and obstetric history does not improve the screening performance for GDM. Future studies...

... test rate with first trimester cell-free DNA (cfDNA) screening for common trisomies and microdeletion 22q11.2 (22q11.2DS) and to examine women’s attitudes toward such an approach. Methods: This is a prospective study at the Prenatal Medicine Department of the University of Tübingen, Germany, at 11–13...

...Nelangi M. Pinto; Kevin A. Henry; Guo Wei; Xiaoming Sheng; Tom Green; Michael D. Puchalski; Janice L.B. Byrne; Anita Y. Kinney Objective: We surveyed obstetric sonographers, who are at the forefront of the screening process to determine how barriers to prenatal cardiac screening impacted screening...

...Stéphanie Friszer; Ferdinand Dhombres; Eléonore Blondiaux; Marie-Laure Moutard; Catherine Garel; Jean-Marie Jouannic Objective: To establish which characteristics of fetal ultrasound screening lead to the diagnosis of posterior fossa (PF) anomalies. Methods: A total of 81 fetuses with PF anomalies...

...) and a short cervix are the best screening tools [ 3,4,5,6,7,8,9 ]. In the last decade, progesterone (even intramuscularly or vaginally) [ 10,11,12,13 ], vaginal pessary [ 14,15 ] and cervical cerclage appear to be the best preventive strategies in high-risk populations [ 16,17,18,19 ]. The ultrasound...

...Caroline Borregaard Miltoft; Camilla B. Wulff; Susanne Kjærgaard; Charlotte K. Ekelund; Ann Tabor; the Danish Fetal Medicine Study Group Introduction: The aim was to investigate the parental decisions about prenatal screening and diagnosis among infants with trisomy 21 (T21) in a national cohort...

... consequences. A maternal screen for Robertsonian translocation carriers would provide women valuable information regarding the risk of fetal trisomy. Harmony results correctly classified all 191 patients as non-trisomy. The FORTE™ algorithm correctly classified the Robertsonian translocation status in all...

.... Aberrant right subclavian artery Congenital heart disease Chromosomal abnormalities Screening De León-Luis et al. [ 5 ] recently published a meta-analysis in which they stressed the need to differentiate isolated ARSA from ARSA associated with other findings in order to better assess the risk...

...C.F. Poon; W.C. Tse; K.O. Kou; K.Y. Leung Objectives: To investigate how the introduction of noninvasive prenatal testing (NIPT) influenced women's testing choices following a positive Down syndrome screening. Methods: A retrospective study was conducted to compare differences in the uptake rates...

...Dahiana Gallo; Leona C. Poon; Mariana Fernandez; David Wright; Kypros H. Nicolaides Objectives: To assess the performance of screening for preeclampsia (PE) by mean arterial pressure (MAP) at 11-13 and at 20-24 weeks' gestation. Methods: MAP was measured at 11-13 and 20-24 weeks in 17,383 singleton...

... to in the content or advertisements. Aneuploidy First trimester Preeclampsia Screening Placental growth factor Isoform Small for gestational age Placenta growth factor (PlGF), an angiogenic glycoprotein that is homologous to vascular endothelial growth factor, exists in at least four isoforms...

...Olav Lapaire; Simon Grill; Sebastien Lalevee; Varaprasad Kolla; Irene Hösli; Sinuhe Hahn Introduction: Our aim was to identify novel biomarker candidates for the near-term prediction of preeclampsia in a homogenous collective. In this study, we screened at the genome-wide level for gene expression...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Screening Trisomy 21 Down syndrome Maternal blood Noninvasive prenatal diagnosis Review Fetal Diagn Ther 2012;31:81 86 DOI: 10.1159/000333060 Received: July 19, 2011...

... detection rate. Perhaps efforts to improve early diagnosis of CCHD could focus on antenatal ultrasound screening techniques for lesions that are missed most often as well as on postnatal screening. 1 09 2010 3 03 2011 28 4 2011 © 2011 S. Karger AG, Basel 2011 Copyright / Drug Dosage...

...Leona C.Y. Poon; George Karagiannis; Violeta Stratieva; Argyro Syngelaki; Kypros H. Nicolaides Objective: To determine if combinations of maternal characteristics and measurements of parameters used in screening for aneuploidies at 11–13 weeks provide significant prediction of macrosomia. Method...

... to in the content or advertisements. Pre-eclampsia Small for gestational age HELLP Screening Adverse outcome First trimester Original Paper Fetal Diagn Ther 2010;27:32 39 DOI: 10.1159/000275669 Received: July 1, 2009 Accepted after revision: October 14, 2009 Published online: January 8, 2010 Maternal...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Ectopic pregnancy Extrauterine Spontaneous abortion Core fragment β-Core Screening hCG Human chorionic gonadotropin Transvaginal ultrasound Fetal I)iai*nosis...

...M. David; N. Israel; R. Merksamer; N. Bar-Nizan; Z. Borochowitz; H. Bar-El; I. Yehudai; H. Dar Twenty-four women out of 7,875 pregnant women who enrolled in a prenatal screening program showed extremely low levels of unconjugated estriol (< 0.15 MOM). In 19 cases, intrauterine fetal death...

... 303,000 individual prenatal clinical services and accounted for more than 481,000 laboratory tests. Advanced maternal age was the primary indication for service in the vast majority of patients (62%). Based on data from the two major proficiency testing programs for laboratories performing screening tests...